Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death.
about
Vitamin E for Alzheimer's dementia and mild cognitive impairmentVitamin E for Alzheimer's disease and mild cognitive impairmentInvolvement of PI3K/PKG/ERK1/2 signaling pathways in cortical neurons to trigger protection by cotreatment of acetyl-L-carnitine and alpha-lipoic acid against HNE-mediated oxidative stress and neurotoxicity: implications for Alzheimer's diseaseEffect of Nutrients, Dietary Supplements and Vitamins on Cognition: a Systematic Review and Meta-Analysis of Randomized Controlled TrialsOvernutrition Determines LPS Regulation of Mycotoxin Induced Neurotoxicity in Neurodegenerative DiseasesHeat shock proteins and hormesis in the diagnosis and treatment of neurodegenerative diseasesNanotechnology-based drug delivery systems for the treatment of Alzheimer's diseaseTranscriptional mutagenesis by 8-oxodG in α-synuclein aggregation and the pathogenesis of Parkinson's diseaseMicroglial cell dysregulation in brain aging and neurodegenerationRole of Oxidative Stress in HIV-1-Associated Neurocognitive Disorder and Protection by Gene Delivery of Antioxidant EnzymesAbeta, oxidative stress in Alzheimer disease: evidence based on proteomics studiesVitamin Supplementation as an Adjuvant Treatment for Alzheimer's DiseaseInsight of brain degenerative protein modifications in the pathology of neurodegeneration and dementia by proteomic profilingCeramides in Alzheimer's Disease: Key Mediators of Neuronal Apoptosis Induced by Oxidative Stress and Aβ AccumulationNeuroprotective properties of the marine carotenoid astaxanthin and omega-3 fatty acids, and perspectives for the natural combination of both in krill oilCharacterizing the novel protein p33MONOXMutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implicationElevated protein carbonylation, and misfolding in sciatic nerve from db/db and Sod1(-/-) mice: plausible link between oxidative stress and demyelinationRedox proteomics analysis to decipher the neurobiology of Alzheimer-like neurodegeneration: overlaps in Down's syndrome and Alzheimer's disease brain.Transduction of redox signaling by electrophile-protein reactionsSleep, plasticity and the pathophysiology of neurodevelopmental disorders: the potential roles of protein synthesis and other cellular processes.Mitochondrial superoxide contributes to blood flow and axonal transport deficits in the Tg2576 mouse model of Alzheimer's disease.Genomic convergence and network analysis approach to identify candidate genes in Alzheimer's disease.Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis.Age-related loss of phospholipid asymmetry in APP(NLh)/APP(NLh) x PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice: relevance to Alzheimer disease.Evidence that gamma-secretase mediates oxidative stress-induced beta-secretase expression in Alzheimer's disease.Chronic dietary supplementation of 4% figs on the modification of oxidative stress in Alzheimer's disease transgenic mouse model.Simultaneous changes of spatial memory and spine density after intrahippocampal administration of fibrillar aβ1-42 to the rat brainInvolvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease.Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease: many pathways to neurodegenerationProtective effect of quercetin on atrazine-induced oxidative stress in the liver, kidney, brain, and heart of adult wistar rats.Neuroprotection by the synthetic neurosteroid enantiomers ent-PREGS and ent-DHEAS against Aβ₂₅₋₃₅ peptide-induced toxicity in vitro and in vivo in miceDocosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse modelReconvene and reconnect the antioxidant hypothesis in human health and disease.Prediction of S-glutathionylated proteins progression in Alzheimer's transgenic mouse model using principle component analysisHydralazine modifies Aβ fibril formation and prevents modification by lipids in vitro.Vitamin E for Alzheimer's dementia and mild cognitive impairment.Oxidative stress in Alzheimer disease: synergy between the Butterfield and Markesbery laboratories.Upregulation of glycolytic enzymes, mitochondrial dysfunction and increased cytotoxicity in glial cells treated with Alzheimer's disease plasma.The application of functional genomics to Alzheimer's disease.
P2860
Q24202844-590033B4-93C4-400C-919D-D9552F51F6E3Q24241955-A549CD4A-40B4-44AF-B677-3A4BE8A9184FQ24684559-0BE4F4D3-8120-4FE8-AEEF-7DEBC3909E85Q26770351-ED8D7909-6651-4448-8887-CDE619D67DC9Q26774272-8D188AD0-B839-4138-9D92-5C7BC2AEFADCQ26778791-20E6A44F-6748-4107-A222-C2D9288C4697Q26783306-D5B5010B-91E3-4547-ADD9-E4E4490C1DA0Q26796502-B091D015-8523-44AA-A7C9-E63F5ED871FAQ26800212-0B3D4897-290E-42D2-9941-02FAAECCB940Q26829535-236485BF-0FCE-4BB7-9B6C-8C7F052E9B23Q27693922-E52A6D95-3DE3-40B1-9580-E6A8396C0A1AQ28073374-A97143AB-6228-47F2-BC9E-D3D8212DDC57Q28076999-F8FA8319-16F3-457A-9935-888698531C7EQ28087030-CA4364CD-3E51-4060-BCBC-3EF0C8F8EC7FQ28236740-020D377D-3851-442A-8E9C-DBA3A79E6EC3Q28509587-B3F0098B-ADB4-4037-AFA1-B357A80EEB37Q28510031-0EA27548-14B3-4DA0-9534-C283501D06A1Q28533621-6E8EBB03-A56D-4685-8E33-F125891AB2D0Q30367032-18CDA48F-13AD-4850-9FC5-2734815F5942Q30381222-FB0F0B2F-D6BD-4FC8-9172-D0EFD7EF5ADFQ30823493-285F1A4A-1D67-4CC6-BA42-4C225093072CQ30982773-CA9AF835-664B-4A7F-9D3D-CD1379B02937Q33637672-0D2E2AD0-EE0C-4E10-9C79-2A0294AC59F2Q33639885-9E86B02A-504E-41D4-837F-AF3A80E3AD9FQ33712475-D4ACF81C-C950-44C5-9F6B-52FC3EBB4847Q33805047-B824ACCF-5E65-4D54-B6E8-4F84393A9A75Q33876485-28F12050-0F82-4177-933A-74DB7E955A63Q33891423-90390D64-C83C-4144-A4AC-CA6E987953A2Q33915362-A7ABFE26-FCFE-475D-90B5-21D675DB9A44Q34071097-BF11D9A1-4E46-4AC4-ACBF-60D47C10F5AEQ34221385-6AF6E950-CB67-4331-ACC7-34AB7DF9F0C6Q34300822-522E389E-D6D1-4BAF-B3C0-C33418E45B05Q34344634-80392E04-B888-45C0-8F3A-53008D748311Q34405837-5965166A-05DA-4E7A-AAEC-FB3C030651E2Q34466540-DCB03385-DB71-4E16-B28E-C02AFC086312Q34549266-A300E563-3468-40FC-A821-6FE2CAD724D6Q34550138-C9AB71E5-F730-4F94-8FD7-8E00CE40CDB4Q34561160-DE9E3D3C-ACF8-46C5-B656-E292591B4E44Q35191570-A6C67B7E-255E-4195-A0B5-F63DC40D5657Q35207554-50661F89-8757-4649-9D55-E33B155930B1
P2860
Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Evidence that amyloid beta-pep ...... contribute to neuronal death.
@ast
Evidence that amyloid beta-pep ...... contribute to neuronal death.
@en
Evidence that amyloid beta-pep ...... contribute to neuronal death.
@nl
type
label
Evidence that amyloid beta-pep ...... contribute to neuronal death.
@ast
Evidence that amyloid beta-pep ...... contribute to neuronal death.
@en
Evidence that amyloid beta-pep ...... contribute to neuronal death.
@nl
prefLabel
Evidence that amyloid beta-pep ...... contribute to neuronal death.
@ast
Evidence that amyloid beta-pep ...... contribute to neuronal death.
@en
Evidence that amyloid beta-pep ...... contribute to neuronal death.
@nl
P2093
P1476
Evidence that amyloid beta-pep ...... contribute to neuronal death.
@en
P2093
Alessandra Castegna
Christopher M Lauderback
Jennifer Drake
P304
P356
10.1016/S0197-4580(01)00340-2
P577
2002-09-01T00:00:00Z